Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Zymeworks (ZYME) Receivables - Other (2022 - 2025)

Zymeworks' Receivables - Other history spans 4 years, with the latest figure at $2.8 million for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 2700.0% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 2700.0% increase, with the full-year FY2025 number at $2.8 million, up 2700.0% from a year prior.
  • Receivables - Other hit $2.8 million in Q4 2025 for Zymeworks, up from $971000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for ZYME hit a ceiling of $3.0 million in Q3 2022 and a floor of $100000.0 in Q4 2024.
  • Historically, Receivables - Other has averaged $1.7 million across 4 years, with a median of $1.9 million in 2025.
  • The widest YoY moves for Receivables - Other: up 2700.0% in 2025, down 2700.0% in 2025.
  • Tracing ZYME's Receivables - Other over 4 years: stood at $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then plummeted by 96.67% to $100000.0 in 2024, then surged by 2700.0% to $2.8 million in 2025.
  • Business Quant data shows Receivables - Other for ZYME at $2.8 million in Q4 2025, $971000.0 in Q3 2025, and $569000.0 in Q2 2025.